Zydus Lifesciences Jumps 6% Despite Q1 Profit Fall
Zydus Lifesciences touched a fresh 52 week high of Rs 1,205 on Tuesday even after its June quarter net profit fell 36% to Rs 939.8...
Tag : Zydus Lifesciences
Zydus Shares Slip Even as USFDA Clears Phase III Trial
Zydus Lifesciences shares slipped 2% on the NSE on Thursday, even after the company cleared a big regulatory hurdle for a new drug trial. The...
Zydus Lifesciences Jumps 4% on Apollo Cancer Test Tie-Up
Zydus Lifesciences hit a fresh 52 week high of Rs 1,142.90 on Friday, 3 July, after tying up with Apollo for a cancer test. The...
Zydus Lifesciences Rises 2% on Sterling Biotech Deal Update
Zydus Lifesciences jumps to Rs 1,125 on 29 June, up 2%, after extending its Sterling Biotech API acquisition deadline to 30 September 2026. Active Pharmaceutical...
Zydus Lifesciences Gets USFDA Nod for MS Drug; Oncology Plant Cleared, Shares Flat
Shares of Zydus Lifesciences Ltd are trading flat after hitting a day’s high of Rs 952.95 on 14th November, even as the company announced it...
Zydus Lifesciences Board Approves Rs 84 Crore Acquisition of Sterling Biotech API Business; Shares Trading Flat
Shares of Zydus Lifesciences Ltd. are trading flat after reaching a day’s high of Rs 1,125 on 17th September, following the board’s approval of the...
Zydus Lifesciences Ltd Q1 Report; Profit Rise 2-Folds; Shares Slump 2%
Shares of Zydus Lifesciences Ltd on Friday, 11 August, were trading in the red even after the company reported a two-fold rise in consolidated net...
Anupam Rasayan, Zee and Zydus Lifesciences Among Top Stocks to Watch Today
The domestic equity indices ended the last trading on a high. BSE Sensex ended 418 points higher, while Nifty gained 114 points. Today, both indices...
Zydus Lifesciences Gets USFDA Approval for Smoking Addiction Treating Drug
Ahmedabad-headquartered pharmaceutical company Zydus Lifesciences announced on Tuesday that it has received approval for manufacturing and marketing a generic version of Varenicline tablets from the...
Zydus Lifesciences Share Hits 52-Week High on USFDA Approval for Osteoporosis Drug
Shares of Zydus Lifesciences hit a 52-week high in morning trade on April 19 after the company said it had received final approval from the...